A truck assembly for a skateboard includes an axle housing, a base, and a kingpin connecting the axle housing and base. The kingpin holds the axle housing and a base surface of the base a predetermined distance apart. The truck further includes a turning mechanism between the axle housing and base, around the kingpin. The turning mechanism includes opposed cam surfaces that are angled along the axis of the kingpin and an elastomeric bushing so that rotating the axle housing about the kingpin pushes the cam surfaces apart, against the compression pressure...
A truck assembly for a skateboard includes an axle housing, a base, and a kingpin connecting the axle housing and base. The kingpin holds the axle housing and a base surface of the base a predetermined distance apart. The truck further includes a turning mechanism between the axle housing and base, around the kingpin. The turning mechanism includes opposed cam surfaces that are angled along the axis of the kingpin and an elastomeric bushing so that rotating the axle housing about the kingpin pushes the cam surfaces apart, against the compression pressure of the elastomeric bushing. The elastomeric bushing may be located within a coiled spring. The truck assembly additionally includes an adjustment mechanism for adjusting the pressure against the bushing. The adjustment mechanism includes an adjustment surface on the base of the truck assembly with two or more adjustment points, each a different distance from the base surface along the direction of the kingpin. An adjustment ring surrounds the kingpin, between the base surface and the turning mechanism. The adjustment ring includes adjustment lobes that engage the adjustment surface on the base. ptor Antagonists in the Management of Diabetes," Blood Pressure, vol. 10, p. 21-26, (2001). Bonnardeaux, A., Et Al., "Angiotensin II Type 1 Receptor Gene Polymorphisms in Human Essential Hypertension," Hypertension, vol. 24, p. 63-69, (1994). Burnier & Maillard, "The Comparative Pharmacology of Angiotensin II Receptor Antagonists," Blood Pressure, vol. 10, p. 6-11, (2001). Erdmann, J., Et Al., "Characterization of Polymorphisms in the Promoter of the Human Angiotensin II Subtype 1 (AT1) Receptor Gene," Ann. Human Genetics, vol. 63, p. 369-374, (1999). Hernandez-Hernandez, R., Et Al., "Angiotensin II Receptor Antagonists in Arterial Hypertension," Journal of Human Hypertension, vol. 14, p. S69-S72, (2000). Herzig, T.C., Et Al., "Angiotensin II Type 1a Receptor Gene Expression in the Heart: AP-1 and GATA-4 Participate in the Response to Pressure Overload," Proc. Natl. Acad. Sci. USA, vol. 94, (No. 14), p. 7543-7548, (1997). Ito, M., Et Al., "Regulation of Blood Pressure by the Type 1A Angiotensin II Receptor Gene," Proc. Natl. Acad. Sci. (USA), vol. 92, (No. 5), p. 3521-3525, (1995). Martin, M.N, Et Al., "Human Angiotensin II Type 1 Receptor Isoforms Encoded by Messenger RNA Splice Variants are Funcitonally Distinct," Mol. Endocrinology, vol. 15, (No. 2), p. 281-293, (2001). Murphy, T.J., Et Al., "Isolation of a cDNA Encoding the Vascular Type-1 Angiotensin II Receptor," Nature, vol. 351, No. 6323, p. 233-236, (1991). Nalogowska-Glosnicka, K., Et Al., "Angiotensin II Type 1 Receptor Gene A1166C Polymorphism is Associated with the Increased Risk of Pregnancy-Induced Hypertension," Medical Science Monitor, vol. 6, No. 3, p. 523-529, (2000). Ramahi, T.M. Et Al., "Expanded Role for ARBs in Cardiovascular and Renal Disease? Recent Observations Have far-Reaching Implications," Postgraduate Medicine, vol. 109, (No. 4), p. 115-122, (2001). Siragy, Helmy, "Angiotensin II Receptor Blockers: Review of the Binding Characteristics," The American Journal of Cardiology, vol. 84, (No. 10A), p. 3S-8S, (1999). Takahashi, N. Et Al., "Association of a Polymorphism at the 5' Region of the Angiotensin II Type 1 Receptor with Hypertension," Ann. Hum. Genet., vol. 64, (No. 3), p. 197-205, (2000). Wang, Wy Et Al., "Association of Angiotensin II Type 1 Receptor Gene Polymorphism with Essential Hypertension," Clinical Genetics, vol. 51, (No. 1), p. 31-43, (1997). oc. Natl. Acad. Sci., USA 82:6731-6735 (1985). Cramer et al., Plant Mol. Biol. 12:367-383 (1989). Lois et al., EMBO J. 8:1641-1648 (1989). Minami et al., Eur. J. Biochem. 185:19-25 (1989). Anson et al., Gene 58:189-199 (1987). Rasmussen & Oerum, DNA Sequence, 1:207-211 (1991). Faulkner et al., Gene 143:13-20 (1994). Langer et al., Biochemistry 36:10867-10871 (1997). McKegney et al., Phytochemistry 41:1259-1263 (1996). Bourget et al., FEBS Lett. 180:5-8 (1985). Fritz et al., J. Biol. Chem. 251:4646-4650 (1976). Koyama et al., Clin. Chim. Acta, 136:131-136 (1984). Yamada et al., Appl. Environ. Microbiol. 42:773 (1981). Hamilton et al., Trends in Biotechnol. 3:64-68 (1985). Evans et al., Microbial Biotechnology 25:399-405 (1987). Pierrel et al., Eur. J. Biochem. 224:835 (1994). Urban et al., Eur. J Biochem. 222:843 (1994). Cabello-Hurtado et al., J. Biol. Chem. 273:7260 (1998). Teutsch et al., Proc. Natl. Acad. Sci. USA 90:4102 (1993). Appert et al., Eur. J. Biochem. 225:491 (1994). Havir et al., Plant Physiol. 48:130 (1971). Hanson and Havir in The Biochemistry of Plants; Academic: New York, 1981; vol. 7, pp 577-625. Rosco et al., Arch. Biochem. Biophys. 348(2) 369-377 (1997). Shet et al., Proc. Natl. Acad. Sci. U.S.A. 90(7) 2890-2894 (1993). Benveniste et al., "Purification and characterisation of the NADPH-cytochrome reductase from higher-plant microsomal fraction" Biochemical Journal, vol. 235, No. 2, 1986, pp 365-374 XP000943859. Bocks, Sheila M., "Fungal metabolism, I. The transformation of coumarin, o-coumaric acid, and trans-cinnamic acid by Aspergillus niger", Phytochemistry (1967) 6(1), 127-30 XP002158519. Gotor et al., Fungal and Bacterial Regioselective Hydroxylation of Pyrimidine Heterocycles Tetrahedron, NL Elsevier Science Publishers, Amsterdam, vol. 53. No. 18, May 5, 1997, pp. 6421-6432 XP004105640.